• EZ Cap™ Human PTEN mRNA: Transforming Tumor Suppressor Studi

  2026-04-23

  EZ Cap™ Human PTEN mRNA empowers precision cancer research and gene therapy by combining Cap 1 structure and robust poly(A) tailing for unmatched stability and translation. Novel workflows, including nanoparticle-based delivery, unlock high-fidelity tumor suppressor restoration and advanced immunotherapy investigations.

• 3X (DYKDDDDK) Peptide: Precision Affinity Purification Unloc

  2026-04-22

  The 3X (DYKDDDDK) Peptide streamlines the purification and detection of recombinant proteins with unparalleled sensitivity and flexibility. By leveraging its trivalent, hydrophilic design, researchers can optimize workflows for challenging applications, from metal-dependent ELISA to protein crystallization and high-throughput structural biology.

• Sequencing Therapies in Waldenström Macroglobulinemia: Genom

  2026-04-22

  This article reviews recent advances in the sequencing of therapies for Waldenström macroglobulinemia (WM), focusing on how genomic profiling—particularly MYD88 and CXCR4 mutations—informs optimal treatment selection. The reference study highlights the clinical relevance of mutation-guided regimens and emerging roles for CXCR4 antagonists, including potential applications in challenging patient subgroups.

• MK-2206 dihydrochloride: Precision PI3K/Akt/mTOR Inhibition

  2026-04-21

  MK-2206 dihydrochloride empowers researchers to dissect the PI3K/Akt/mTOR axis in cancer, bone, and metabolic studies with nanomolar precision. This guide details actionable workflows, troubleshooting tactics, and translational tips, bridging breakthrough O-GlcNAcylation insights with practical apoptosis and metabolic assays.

• Morin: Applied Protocols and Innovations in Mitochondrial Re

  2026-04-21

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) empowers researchers with both mechanistic insight and advanced assay flexibility—serving as a unique, high-purity natural flavonoid for mitochondrial, metabolic, and fluorescent probe applications. Recent studies reveal Morin’s targeted inhibition of adenosine 5′-monophosphate deaminase, making it indispensable for energy metabolism modeling and disease research.

• Surfactant-Derived LNPs Enable Efficient mRNA Delivery to Ma

  2026-04-20

  This study introduces a dual-component lipid nanoparticle (LNP) system based on surfactant-derived ionizable lipids and fusogenic lipids for mRNA delivery to macrophages. The innovation addresses challenges in non-viral delivery to hard-to-transfect immune cells, with implications for research in gene regulation, immunotherapy, and mRNA-based technologies.

• WY-14643 (Pirinixic Acid): Selective PPARα Agonist for Metab

  2026-04-20

  WY-14643 (Pirinixic Acid) is a highly potent and selective agonist of PPARα, central to lipid metabolism and inflammation regulation. It demonstrates dual PPARα/γ activity in the low micromolar range and is widely employed in metabolic disorder research. Benchmarked animal studies show significant improvement in insulin sensitivity, lipid profiles, and reduction of inflammatory markers.

• Plk1 Regulation of p31comet and Mitotic Checkpoint Disassemb

  2026-04-19

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the mitotic checkpoint by suppressing the disassembly of mitotic checkpoint complexes via phosphorylation of p31comet. These findings clarify a previously ambiguous control mechanism, with implications for understanding cell cycle fidelity and potential therapeutic targeting.

• Erastin as a Ferroptosis Research Tool: Mechanistic Depth &

  2026-04-18

  Explore how Erastin, a leading ferroptosis inducer, provides unprecedented mechanistic clarity and translational potential in cancer biology and oxidative stress research. This article uniquely bridges molecular action, biomarker selection, and practical assay optimization.

• Strategic Use of Mifepristone (RU486) in Translational Oncol

  2026-04-17

  Explore advanced applications of Mifepristone (RU486) in translational research, with mechanistic insights into tumor suppression, protocol optimization, and the evolving landscape of hormone receptor-targeted therapies. This article bridges experimental evidence, clinical relevance, and workflow strategy, highlighting APExBIO's offering and drawing from landmark findings in prostate cancer heterogeneity.

• Tigecycline: Applied Workflows for Multidrug-Resistant Bacte

  2026-04-16

  Tigecycline, a pioneering glycylcycline antibiotic, empowers researchers with robust experimental workflows against multidrug-resistant pathogens such as MRSA and CREC. This article dissects real-world use-cases, evidence-driven protocol enhancements, and troubleshooting strategies that drive success in complex resistance models.

• Thiazovivin as a ROCK Inhibitor in Stem Cell Workflows

  2026-04-15

  Thiazovivin addresses key technical barriers in induced pluripotent stem cell generation and human embryonic stem cell survival by inhibiting the ROCK signaling pathway. It is best applied where high-efficiency reprogramming or post-dissociation cell viability is required. Thiazovivin should not be used for diagnostic or clinical purposes.

• FK866 (APO866): Expanding NAMPT Inhibition Beyond Hematologi

  2026-04-14

  Explore how FK866 (APO866) revolutionizes cancer research as a selective NAMPT inhibitor. This article delivers deeper insight into its mechanism and highlights new translational opportunities in NAD metabolism and combination therapies.

• Spermine Tetrahydrochloride: Bridging Mechanism to Translati

  2026-04-13

  This article examines the mechanistic underpinnings and translational potential of Spermine tetrahydrochloride, highlighting its unique role in stabilizing biomolecular structures, enhancing NMDA receptor signaling research, and enabling next-generation workflows in neuroscience and structural biology. By synthesizing recent experimental results, best-practice protocols, and strategic guidance, we position APExBIO’s Spermine tetrahydrochloride as a cornerstone reagent for researchers seeking to bridge discovery and clinical solutions.

• Neuroinflammation and CGRP/SP-Piezo2 Axis in Trigeminal Allo

  2026-04-12

  Liao et al. (2026) identify a neuroinflammatory feedback loop involving the CGRP/SP-Piezo2 axis and Ca2+ signaling as a driver of mechanical allodynia in trigeminal neuralgia. This mechanistic insight links ATP-driven pathways to tactile hypersensitivity, highlighting novel targets for pain modulation.

457 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page